ArticleJournal of cancer research and clinical oncology2023

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.

Ehab Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.